Concepedia

Daniel Cua

DC

Statistics

Publications

13

Citations

2.4K

H-Index

13

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

Beth Israel Deaconess Medical Center

Medical College of Wisconsin

University of Alabama at Birmingham

Daniel Cua is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, life sciences, and immunoregulation.

Publications per year

1994–2020

13

Publications

13

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

Dror Luger, Phyllis B. Silver, Jun Tang et al. · The Journal of Experimental Medicine · 2008 · 714 citations · Full text

, , +17

RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota

Shinichiro Sawa, Matthias Lochner, Naoko Satoh‐Takayama et al. · Nature Immunology · 2011 · 559 citations · Full text

, , +17

The Cytokines Interleukin 27 and Interferon-γ Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology

Aisling O’Hara Hall, Daniel P. Beiting, Cristina M. Tato et al. · Immunity · 2012 · 346 citations · Full text

, , +14

The Toll–Interleukin-1 Receptor Member SIGIRR Regulates Colonic Epithelial Homeostasis, Inflammation, and Tumorigenesis

Hui Xiao, Muhammet F. Gülen, Jinzhong Qin et al. · Immunity · 2007 · 334 citations · Full text

, , +10

Immunization with<i>Staphylococcus aureus</i>iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model

Amita Joshi, Greg Pancari, Leslie D. Cope et al. · Human Vaccines & Immunotherapeutics · 2012 · 113 citations · Full text

, , +17

1–5 of 13